헬웰AI (AIDX) 주가

헬웰AI(AIDX)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $0.55 (+6.25%), 시가총액 $0.01B, 52주 범위 $1.37 ~ $23.85.

20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups. The company was formerly known as 20/20 GeneSystems, Inc. and changed its name to 20/20 Biolabs, Inc. in March 2025. The company was incorporated in 2000 and is based in Gaithersburg, Maryland.

핵심 지표

• 현재가: $0.55 (+6.25%)
• 시가총액: $0.01B
• 52주 최저~최고: $1.37 ~ $23.85
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NASDAQ

헬웰AI의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.

헬웰AI 재무 요약

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 317.43
• 순이익률: -1.83%
• 영업이익률: -1.70%

자주 묻는 질문